Towards Healthcare
GMP Peptides Market to Grow at 8.35% CAGR till 2034

GMP Peptides Market Outlook 2025 with AI and Oncology Boost

Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives the global market. North America dominated the global market due to the presence of key players and the availability of state-of-the-art research and development facilities.

Content

  • Last Updated: 22 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The GMP peptides market stands at USD 1.41 billion in 2025 and is expected to reach USD 2.9 billion by 2034, growing at a CAGR of 8.35% from 2024 to 2034.

North America is leading the GMP peptides market share by 38.95% due to the availability of state-of-the-art research and development facilities and the increasing adoption of advanced technologies.

The GMP peptides market includes six segments by type, by synthesis method, by service type, by application area, by end-use, and by region.

Key trends include the rising prevalence of chronic disorders, advancements in manufacturing technologies, and increasing investments.

Peptides are used for a wide range of purposes, including medical treatments, cosmetic applications, and as nutritional supplements.

Food and Drug Administration, Government of Canada, Press Information Bureau, GOV.UK
Any Questions